It has been shown that platelet-derived TGF-β has an immunosuppressive effect, primarily affecting T cells, and that the deletion of Lrrc32 (the gene encoding GARP) enhances the protective effect of the immune system against both melanoma and colon cancer. Here, LRRC32 is linked to colonic neoplasm.